Safety and immunogenicity of the CIGB 2020. |
Zinc-Children-Hospitalized-Pneumonia |
Second Line-Acute Asthma |
PLASMA TREATMENT TO ASYMPTOMATIC PATIENT WITH COVID-19 INFECTION |
Stem cells in patients with lung lesions (COVID-19) |
VIDA study |
Rectal Ozone in the COVID-19 treatment |
Biomodulina T - IM - covid-19 - older adult |
Heberon Alfa R in COVID-19 |
ATENEA-Co-300 study |
Exploratory study of BMT EV to stimulate immune response in patients with CKD-5 on iterated hemodialysis |
Evaluation of the synergistic effect of sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study |
VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2 |
CIGB-258 at COVID-19 |
PrevengHo-Vir Homeoprohylaxis COVID-2019 |
Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumab |
Biomodulina T - IM- covid-19 - older adultos - Phase IV clinical trial |
Therapy for COVID-19-Phase I-II |
Pharmacodynamics of the Nasalferon in healthy volunteers. |
ESPERANZA study |